EndoC-βH1 multi-genomic profiling defines gene regulatory programs governing human pancreatic β cell identity and function

Nathan Lawlor,Eladio J. Marquez,Peter Orchard,Narisu Narisu,Muhammad Saad Shamim,Asa Thibodeau,Arushi Varshney,Romy Kursawe,Michael R. Erdos,Matt Kanke,Huiya Gu,Evgenia Pak,Amalia Dutra,Sheikh Russell,Xingwang Li,Emaly Piecuch,Oscar Luo,Peter S. Chines,Christian Fuchbserger,Praveen Sethupathy,Aviva Presser Aiden,Yijun Ruan,Erez Lieberman Aiden,Francis S. Collins,Duygu Ucar,Stephen C.J. Parker,Michael L. Stitzel
DOI: https://doi.org/10.1101/399139
2018-01-01
bioRxiv
Abstract:EndoC-βH1 is emerging as a critical human beta cell model to study the genetic and environmental etiologies of beta cell function, especially in the context of diabetes. Comprehensive knowledge of its molecular landscape is lacking yet required to fully take advantage of this model. Here, we report extensive chromosomal (spectral karyotyping), genetic (genotyping), epigenetic (ChIP-seq, ATAC-seq), chromatin interaction (Hi-C, Pol2 ChIA-PET), and transcriptomic (RNA-seq, miRNA-seq) maps of this cell model. Integrated analyses of these maps define known (e.g., PDX1, ISL1) and putative (e.g., PCSK1, mir-375) beta cell-specific chromatin interactions and transcriptional cis-regulatory networks, and identify allelic effects on cis-regulatory element use and expression. Importantly, comparative analyses with maps generated in primary human islets/beta cells indicate substantial preservation of chromatin looping, but also highlight chromosomal heterogeneity and fetal genomic signatures in EndoC-βH1. Together, these maps, and an interactive web application we have created for their exploration, provide important tools for the broad community in the design and success of experiments to probe and manipulate the genetic programs governing beta cell identity and (dys)function in diabetes.
What problem does this paper attempt to address?